What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Discover key insights every first time investor should know. Equip yourself with the knowledge for a successful and rewarding investing experience.
28,352 articlesA MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
In 2022, the market dropped hard, but some dividend-focused funds held up better than the broad index. This article e...
Investors are flocking to renewable energy stocks as policy support and expanding clean-energy projects push the sect...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
Investors eye a $100,000 ultra-high-yield portfolio as rates pause and markets prize cash flow. The model promises ro...
Navitas Semiconductor is shifting from consumer power chips to high-power markets, aligning with Nvidia's AI data-cen...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...